Year
2023
-
Agenus Rises on Fast Track Tag for Cancer Combo Drug
-
Gamida Cell receives FDA approval for blood cancer therapy
-
Acadia commercialises first US Rett Syndrome drug
-
FDA Expands AbbVie’s (ABBV) Qulipta Label in Chronic Migraine
-
University of Rochester researchers discover how to steer army of immune cells toward cancer
-
Sleeping pill reduces levels of Alzheimer’s proteins
-
A gene involved in Down syndrome puts the brakes on neurons’ activity in mice, new study shows
-
Dr. Reddy’s Laboratories Announces the Launch of Treprostinil Injection in the U.S.
-
Big pharma’s patent cliff is fast approaching
-
Trinity team develops promising gene therapy for glaucoma